Terms: = Bone cancer AND TFG, TF6, 10342, ENSG00000114354, Q92734
9 results:
1. Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy.
Baranov E; Winsnes K; O'Brien M; Voss SD; Church AJ; Janeway KA; DuBois SG; Davis JL; Al-Ibraheemi A
Histopathology; 2022 Aug; 81(2):215-227. PubMed ID: 35543076
[TBL] [Abstract] [Full Text] [Related]
2. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
[TBL] [Abstract] [Full Text] [Related]
3. Deregulation of CLTC interacts with tfg, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways.
Shijie L; Zhen P; Kang Q; Hua G; Qingcheng Y; Dongdong C
Clin Transl Med; 2021 Jun; 11(6):e377. PubMed ID: 34185412
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal bone Cysts.
Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
[TBL] [Abstract] [Full Text] [Related]
5. HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma.
Urbini M; Astolfi A; Pantaleo MA; Serravalle S; Dei Tos AP; Picci P; Indio V; Sbaraglia M; Benini S; Righi A; Gambarotti M; Gronchi A; Colombo C; Dagrada GP; Pilotti S; Maestro R; Polano M; Saponara M; Tarantino G; Pession A; Biasco G; Casali PG; Stacchiotti S
Genes Chromosomes Cancer; 2017 Jul; 56(7):582-586. PubMed ID: 28383167
[TBL] [Abstract] [Full Text] [Related]
6. Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies.
Cipriani NA; Agarwal S; Dias-Santagata D; Faquin WC; Sadow PM
Thyroid; 2017 Jun; 27(6):819-824. PubMed ID: 28293986
[TBL] [Abstract] [Full Text] [Related]
7. MRI features of extraskeletal myxoid chondrosarcoma.
Tateishi U; Hasegawa T; Nojima T; Takegami T; Arai Y
Skeletal Radiol; 2006 Jan; 35(1):27-33. PubMed ID: 16220270
[TBL] [Abstract] [Full Text] [Related]
8. Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy.
Dolan V; Murphy M; Sadlier D; Lappin D; Doran P; Godson C; Martin F; O'Meara Y; Schmid H; Henger A; Kretzler M; Droguett A; Mezzano S; Brady HR
Am J Kidney Dis; 2005 Jun; 45(6):1034-9. PubMed ID: 15957132
[TBL] [Abstract] [Full Text] [Related]
9. Serum concentrations of transforming growth factor-beta 1 in patients with benign and malignant prostatic diseases.
Wolff JM; Fandel TH; Borchers H; Jakse G
Anticancer Res; 1999; 19(4A):2657-9. PubMed ID: 10470214
[TBL] [Abstract] [Full Text] [Related]
